Mga Batayang Estadistika
| LEI | P31Q1NLTW35JJGHA4667 |
| CIK | 939334 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to RIT Capital Partners Plc
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 19, 2021 |
SC 13G 1 s13gpanacea.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PANACEA ACQUISITION CORP. II (Name of Issuer) Class A Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) G6882C106 (CUSIP Number) (Name, Address and Telephone Number of Person Authorized to Receive Notices |
|
| August 27, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Amendment No. |
|
| September 24, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Original Filing) NILE THERAPEUTICS, INC. |
|
| January 11, 2007 |
EX-99.1 2 dex991.htm POWER OF ATTORNEY Exhibit 99.1 POWER OF ATTORNEY RIT Capital Partners plc, a public limited company organized under the laws of England and Wales (the “Company”), does hereby nominate, appoint and authorize Mr. Tim Whyte, its attorney-in-fact, with full power and authority to execute, verify and file or cause to be executed or filed all forms on behalf of the Company relating |
|
| January 11, 2007 |
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a) Far East Energy Corporation (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 307325100 (CUSIP Number) Christopher Wise RIT Capital Partners plc 27 St. James Pl |
|
| November 2, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Far East Energy Corporation (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 307325100 (CUSIP Number) Christopher Wise RIT Capital Partners plc 27 St. James Place London SW1A 1NR England (Name, Address and Telephone Number of Person Authorized |
|
| May 2, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 FUEL-TECH N. |
|
| October 7, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2 (Original Filing) AXS-ONE INC. |
